1. |
Dunn DW, Austin JK. Differential diagnosis and treatment of psychiatric disorders in children and adolescents with epilepsy. Epilepsy Behav, 2004, 5(supp1 3): S10-17.
|
2. |
Plioplys S, Dunn DW, Caplan R. 10‐year research update review: psychiatric problems in children with epilepsy. J Am Acad Child Adolesc Psychiatry, 2007, 46: 1389-1402.
|
3. |
Cohen R, Senecky Y, Shuper A, et al. Prevalence of epilepsy and attention‐deficit hyperactivity (ADHD) disorder: a population based study. J Child Neurol, 2013, 28: 120-123.
|
4. |
Powell K, Walker RW, Rogathe J, et al. Cognition and behavior in a prevalent cohort of children with epilepsy in rural northern tanzania: a three-year follow-up study. Epilepsy Behav, 2015, 51(1): 117-123.
|
5. |
Chou IC, Chang YT, Chin ZN, et al. Correlation between epilepsy and attention deficit hyperactivity disorder: a population based cohort study. PLoS ONE, 2013, 8: e57926.
|
6. |
Aaberg KM, Bakken IJ, Lossius MI, et al. Comorbidity and childhood epilepsy: a nationwide registry study. Pediatrics, 2016, 138: pii: e20160921.
|
7. |
Brikell I, Ghirardi L, D’Onofrio BM, et al. Familial Liability to Epilepsy and Attention‐Deficit/Hyperactivity Disorder: A Nationwide Cohort Study. Biol Psychiatry, 2018, 83: 173-180.
|
8. |
Schatz DB, Rostain AL. ADHD with comorbid anxiety: a review of the current literature. J Atten Disord, 2006, 10: 141-149.
|
9. |
Austin JK, Harezlak J, Dunn DW, et al. Behavior problems in children before first recognized seizures. Pediatrics, 2001, 107(1): 115-122.
|
10. |
Pliszka S, ACAP Work Group on Quality Issues. Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/ hyperactivity disorder. J Am Acad Child Adolesc Psychiatry, 2007, 46(7): 894-921.
|
11. |
Subcommittee on Attention-Deficit/Hyperactivity Disorder, Steering Committee on Quality Improvement and Management, Wolraich M, et al. ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/ hyperactivity disorder in children and adolescents. Pediatrics, 2011, 128(5): 1007-1022.
|
12. |
Kendall T, Taylor E, Perez A, et al. Diagnosis and management of attention-deficit/ hyperactivity disorder in children, young people, and adults: summary of NICE guidance. BMJ, 2008, 337(1): a1239.
|
13. |
Taylor E, Döpfner M, Sergeant J, et al. European clinical guidelines for hyperkinetic disorder - first upgrade. Eur Child Adolesc Psychiatry, 2004, 13(Suppl 1): I7-I30.
|
14. |
Pelham WE Jr, Fabiano GA, Massetti GM. Evidence-based assessment of attention deficit hyperactivity disorder in children and adolescents. J Clin Child Adolesc Psychol, 2005, 34(3): 449-476.
|
15. |
Hesdorffer DC, Baldin E, Caplan R, et al. How do we measure psychiatric diagnoses? Implications of the choice of instruments in epilepsy. Epilepsy Behav, 2014, 31(2): 351-355.
|
16. |
Tanabe T, Kashiwagi M, Shimakawa S, et al. Outpatient screening of Japanese children with epilepsy for attention-deficit/ hyperactivity disorder (AD/HD). Brain Dev, 2014, 36(4): 301-305.
|
17. |
Loutfi KS, Carvalho AM, Lamounier JA, et al. ADHD and epilepsy: contributions from the use of behavioral rating scales to investigate psychiatric comorbidities. Epilepsy Behav, 2011, 20(3): 484-489.
|
18. |
Goodman R, Ford T, Richards H, et al. The development and well‐being assessment: description and initial validation of an integrated assessment of child and adolescent psychopathology. J Child Psychol Psychiatry, 2000, 41(2): 645-655.
|
19. |
Achenbach TM, Rescorla LA. Manual for the ASEBA school-age forms & profiles. Burlington, V.T.: University of Vermont, Research Center for Children, Youth, & Families; 2001.
|
20. |
Bussing R, Fernandez M, Harwood M, et al. Parent and teacher SNAP-IV ratings of attention deficit hyperactivity disorder symptoms: psychometric properties and normative ratings from a school district sample. Assessment, 2008, 15(3): 317-328.
|
21. |
Black DW, Moyer T. Clinical features and psychiatric comorbidity of subjects with pathological gambling behavior. Psychiatr Serv, 1998, 49(11): 1434-1439.
|
22. |
Carballo JJ, Rodríguez-Blanco L, García-Nieto R, et al. Screening for the ADHD phenotype using the strengths and difficulties questionnaire in a clinical sample of newly referred children and adolescents. J Atten Disord, 2018, 22(11): 1032-1039.
|
23. |
Ullebø AK, Posserud MB, Heiervang E, et al. Screening for the attention deficit hyperactivity disorder phenotype using the strength and difficulties questionnaire. Eur Child Adolesc Psychiatry, 2011, 20(9): 451-458.
|
24. |
Dunn DW, Kronenberger WG. Childhood epilepsy, attention problems, and ADHD: review and practical considerations. Semin Pediatr Neurol, 2005, 12(4): 222-228.
|
25. |
Deb S, Dhaliwal AJ, Roy M. The usefulness of conners' rating scales-revised in screening for attention deficit hyperactivity disorder in children with intellectual disabilities and borderline intelligence. J Intellect Disabil Res, 2008, 52(11): 950-965.
|
26. |
Freeman NC, Gray KM, Taffe JR, et al. Development of a new attention rating scale for children with intellectual disability: the scale of attention in intellectual disability (SAID). Am J Intellect Dev Disabil, 2015, 120(2): 91-109.
|
27. |
Flowers A, McDougle L. In search of an ADHD screening tool for African American children. J Natl Med Assoc, 2010, 102(5): 372-374.
|
28. |
Valo S, Tannock R. Diagnostic instability of DSM-IV ADHD subtypes: effects of informant source, instrumentation, and methods for combining symptom reports. J Clin Child Adolesc Psychol, 2010, 39(6): 749-760.
|
29. |
Grodzinsky GM, Barkley RA. Predictive power of frontal lobe tests in the diagnosis of attention deficit hyperactivity disorder. Clin Neuropsychol, 1999, 13(1): 12-21.
|
30. |
Sims DM, Lonigan CJ. Multi-Method assessment of ADHD characteristics in preschool children: relations between measures. Early Child Res Q, 2012, 27(2): 329-337.
|
31. |
Helmstaedter C, Schoof K, Rossmann T, et al. Introduction and first validation of epiTrack junior, a screening tool for the assessment of cognitive side effects of antiepileptic medication on attention and executive functions in children and adolescents with epilepsy. Epilepsy Behav, 2010, 19(1): 55-64.
|
32. |
Williams J, Sharp GB, DelosReyes E, et al. Symptom differences in children with absence seizures versus inattention. Epilepsy Behav, 2002, 3(3): 245-248.
|
33. |
Rosenow F, Wyllie E, Kotagal P, et al. Staring spells in children: descriptive features distinguishing epileptic and nonepileptic events. J Pediatr, 1998, 133(5): 660-663.
|
34. |
Wirrell EC, Camfield PR, Gordon KE, et al. Will a critical level of hyperventilation-induced hypocapnia always induce an absence seizure? Epilepsia, 1996, 37(5): 459-462.
|
35. |
Sillanpää M. Epilepsy in children: prevalence, disability, and handicap. Epilepsia, 1992, 33(3): 444-449.
|
36. |
Camfield C, Camfield P. Preventable and unpreventable causes of childhood‐onset epilepsy plus mental retardation. Pediatrics, 2007, 120: e52-e55.
|
37. |
Berg AT, Langfitt JT, Testa FM, et al. Global cognitive function in children with epilepsy: a community-based study. Epilepsia, 2008, 49(4): 608-614.
|
38. |
Mitchell WG, Chavez JM, Lee H, et al. Academic under achievement in children with epilepsy. J Child Neurol, 1991, 6(1): 65-72.
|
39. |
Ekinci O, Isik U, Gunes S, et al. Understanding sleep problems in children with epilepsy: associations with quality of life, attention-deficit hyperactivity disorder and maternal emotional symptoms. Seizure, 2016, 40(2): 108-113.
|
40. |
Masur D, Shinnar S, Cnaan A, et al. Pretreatment cognitive deficits and treatment effects on attention in childhood absence epilepsy. Neurology, 2013, 81(18): 1572-1580.
|
41. |
Glauser TA, Cnaan A, Shinnar S, et al. Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy. N Engl J Med, 2010, 362(9): 790-799.
|
42. |
Levisohn PM, Mintz M, Hunter SJ, et al. Neurocognitive effects of adjunctive levetiracetam in children with partial-onset seizures: a randomized, double-blind, placebo-controlled, noninferiority trial. Epilepsia, 2009, 50(11): 2377-2389.
|
43. |
Donati F, Gobbi G, Campistol J, et al. Effects of oxcarbazepine on cognitive function in children and adolescents with partial seizures. Neurology, 2006, 67(4): 679-682.
|
44. |
Kang HC, Eun BL, Wu Lee C, et al. The effects on cognitive function and behavioral problems of topiramate compared to carbamazepine as monotherapy for children with benign rolandic epilepsy. Epilepsia, 2007, 48(9): 1716-1723.
|
45. |
Powell K, Walker RW, Rogathe J, et al. Cognition and behavior in a prevalent cohort of children with epilepsy in rural northern Tanzania: a three-year follow-up study. Epilepsy Behav, 2015, 51(2): 117-123.
|
46. |
Samaitienė R, Norkūnienė J, Jurkevičienė G, et al. Behavioral problems in children with benign childhood epilepsy with centrotemporal spikes treated and untreated with antiepileptic drugs. Medicina (Kaunas), 2012, 48(7): 338-344.
|
47. |
Coppola G, Verrotti A, Resicato G, et al. Topiramate in children and adolescents with epilepsy and mental retardation: a prospective study on behavior and cognitive effects. Epilepsy Behav, 2008, 12(2): 253-256.
|
48. |
Torres A, Whitney J, Rao S, et al. Tolerability of atomoxetine for treatment of pediatric attention-deficit/ hyperactivity disorder in the context of epilepsy. Epilepsy Behav, 2011, 20(1): 95-102.
|
49. |
Wernicke JF, Holdridge KC, Jin L, et al. Seizure risk in patients with attention-deficit-hyperactivity disorder treated with atomoxetine. Dev Med Child Neurol, 2007, 49(7): 498-502.
|
50. |
Gonzalez-Heydrich J, Hsin O, Gumlak S, et al. Comparing stimulant effects in youth with ADHD symptoms and epilepsy. Epilepsy Behav, 2014, 36(3): 102-107.
|
51. |
Mulas F, Roca P, Ros-Cervera G, et al. Pharmacological management of attention deficit hyperactivity disorder with methylphenidate and atomoxetine within a context of epilepsy. Rev Neurol, 2014, 58(Suppl 1): 43-49.
|
52. |
Carreras-Saez IP-M. Atomoxetine treatment in patients with attention deficit hyperactivity disorder and epilepsy. International Child Neurology Congress. Iguacu Falls, Brazil; 2016.
|
53. |
Montano CB, Young J. Discontinuity in the transition from pediatric to adult health care for patients with attention-deficit/ hyperactivity disorder. Postgrad Med, 2012, 124(5): 23-32.
|
54. |
Blum RW. Introduction. Improving transition for adolescents with special health care needs from pediatric to adult-centered health care. Pediatrics, 2012, 110(6 Pt 2): 1301-1303.
|
55. |
Andrade DM, Bassett AS, Bercovici E, et al. Epilepsy: transition from pediatric to adult care. Recommendations of the ontario epilepsy implementation task force. Epilepsia, 2017, 58(5): 1502-1517.
|
56. |
Nabbout R, Andrade DM, Bahi-Buisson N, et al. Outcome of childhood-onset epilepsy from adolescence to adulthood: transition issues. Epilepsy Behav, 2017, 69(5): 161-169.
|
57. |
Reale L, Frassica S, Gollner A, et al. Transition to adult mental health services for young people with attention deficit hyperactivity disorder in italy: parents' and clinicians' experiences. Postgrad Med, 2015, 127(7): 671-676.
|